Insiders · Profile

Cataldo Tony

CEO at GT Biopharma. Filing since 6 Feb 2019. CIK 0001450565

Company
Date
Role
Action
Shares
Amount
Of holding
2 Jun 2020
CEO
Sold, plan not stated
4,234,320
$4.23K
39.4%
6 Feb 2019
Director
Sold, plan not stated
800,000
$800.00
16.6%
2 decisions on file.